Stock listing
NASDAQ:KYMR Kymera Therapeutics, Inc. Stock
Home listing (NASDAQ) of Kymera Therapeutics, Inc.
Follow Kymera Therapeutics, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:KYMR
$127.51 USD +0.88 (+0.7%)
Close on Nov 2, 2026
- Day range
- $124.30 – $129.34 USDNov 2, 2026
- Volume
- 1.29M sharesNov 2, 2026
- Market cap
- $10.49B USDAt the close on Nov 2, 2026 · price × 82.26M shares outstanding
- 52-week range
- $55.66 – $130.05 USDLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
- Traded on an average day
- $89.83M USDMedian day 704,500 shares · last 3 months, Aug 3, 2026 – Nov 2, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:KYMR · Home | $127.51 USD | +0.88 (+0.7%) | 1,294,485 | $127.00 | $129.34 | $124.30 | $126.63 | Close on Nov 2, 2026 |
Daily closes
Last 3 months, Aug 3, 2026 – Nov 2, 2026 · NASDAQ:KYMR · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $127.51 | +0.88 | +0.7% | $127.00 | $129.34 | $124.30 | 1,294,485 | |
| $126.63 | +4.03 | +3.3% | $122.58 | $127.26 | $117.31 | 1,591,029 | |
| $122.60 | +0.09 | +0.1% | $123.00 | $127.74 | $117.74 | 1,045,346 | |
| $122.51 | +4.94 | +4.2% | $117.00 | $122.91 | $115.46 | 766,098 | |
| $117.57 | +2.73 | +2.4% | $114.15 | $119.56 | $111.15 | 827,854 | |
| $114.84 | +4.08 | +3.7% | $111.96 | $115.22 | $110.31 | 438,503 | |
| $110.76 | -0.09 | -0.1% | $110.85 | $111.83 | $109.05 | 517,100 | |
| $110.85 | -1.78 | -1.6% | $111.43 | $113.74 | $110.13 | 850,300 | |
| $112.63 | -0.83 | -0.7% | $113.38 | $115.75 | $112.52 | 1,056,300 | |
| $113.46 | +5.39 | +5.0% | $108.75 | $115.28 | $108.49 | 705,000 | |
| $108.07 | +3.29 | +3.1% | $106.56 | $109.16 | $105.10 | 683,200 | |
| $104.78 | -3.36 | -3.1% | $108.19 | $108.59 | $104.39 | 488,700 | |
| $108.14 | +1.31 | +1.2% | $106.75 | $110.68 | $104.63 | 821,000 | |
| $106.83 | +0.15 | +0.1% | $106.39 | $108.08 | $105.58 | 1,029,100 | |
| $106.68 | -5.40 | -4.8% | $110.83 | $112.06 | $106.52 | 779,100 | |
| $112.08 | -0.32 | -0.3% | $111.61 | $113.13 | $110.52 | 537,500 | |
| $112.40 | +3.10 | +2.8% | $109.54 | $115.82 | $107.46 | 1,305,200 | |
| $109.30 | +0.95 | +0.9% | $106.52 | $110.04 | $104.19 | 1,044,700 | |
| $108.35 | +2.37 | +2.2% | $104.58 | $108.68 | $103.45 | 1,167,400 | |
| $105.98 | -3.87 | -3.5% | $111.03 | $111.04 | $101.75 | 960,700 | |
| $109.85 | +2.46 | +2.3% | $108.38 | $109.92 | $103.33 | 729,700 | |
| $107.39 | -2.73 | -2.5% | $111.23 | $111.23 | $106.53 | 870,200 | |
| $110.12 | -1.67 | -1.5% | $111.79 | $116.20 | $109.41 | 1,051,100 | |
| $111.79 | +1.28 | +1.2% | $110.74 | $115.69 | $108.03 | 1,022,600 | |
| $110.51 | -1.49 | -1.3% | $110.54 | $111.92 | $108.97 | 448,200 | |
| $112.00 | +0.05 | 0.0% | $111.95 | $113.60 | $110.51 | 723,700 | |
| $111.95 | -3.86 | -3.3% | $115.99 | $116.20 | $111.42 | 698,400 | |
| $115.81 | +0.34 | +0.3% | $115.28 | $116.41 | $111.37 | 841,700 | |
| $115.47 | -6.59 | -5.4% | $121.29 | $123.00 | $112.91 | 969,600 | |
| $122.06 | +4.39 | +3.7% | $119.03 | $122.37 | $117.88 | 779,400 | |
| $117.67 | -0.08 | -0.1% | $117.75 | $119.53 | $116.61 | 636,900 | |
| $117.75 | -0.73 | -0.6% | $119.06 | $119.06 | $116.36 | 1,900,300 | |
| $118.48 | +2.15 | +1.8% | $119.12 | $122.13 | $118.27 | 570,500 | |
| $116.33 | +3.18 | +2.8% | $113.06 | $117.43 | $112.88 | 653,800 | |
| $113.15 | -1.48 | -1.3% | $114.50 | $114.50 | $110.29 | 900,900 | |
| $114.63 | -0.33 | -0.3% | $116.01 | $117.85 | $114.32 | 499,000 | |
| $114.96 | -2.04 | -1.7% | $118.40 | $119.93 | $113.74 | 574,200 | |
| $117.00 | +1.57 | +1.4% | $116.05 | $119.63 | $114.35 | 734,300 | |
| $115.43 | -1.04 | -0.9% | $115.34 | $120.67 | $113.18 | 767,400 | |
| $116.47 | -0.92 | -0.8% | $114.41 | $120.22 | $113.97 | 631,800 | |
| $117.39 | +0.11 | +0.1% | $115.09 | $118.28 | $112.77 | 378,600 | |
| $117.28 | -1.35 | -1.1% | $118.63 | $119.26 | $115.55 | 591,600 | |
| $118.63 | -0.42 | -0.4% | $119.58 | $123.54 | $117.42 | 983,000 | |
| $119.05 | +0.24 | +0.2% | $116.92 | $119.79 | $116.28 | 576,600 | |
| $118.81 | +0.66 | +0.6% | $118.60 | $119.93 | $115.97 | 656,800 | |
| $118.15 | -2.08 | -1.7% | $119.40 | $121.98 | $117.48 | 415,900 | |
| $120.23 | -5.32 | -4.2% | $124.99 | $125.07 | $119.98 | 595,400 | |
| $125.55 | -1.09 | -0.9% | $126.24 | $126.32 | $123.39 | 558,000 | |
| $126.64 | +5.59 | +4.6% | $122.64 | $127.85 | $121.60 | 925,754 | |
| $121.05 | +1.25 | +1.0% | $119.98 | $121.56 | $116.46 | 466,859 | |
| $119.80 | -1.70 | -1.4% | $122.87 | $125.71 | $119.77 | 503,400 | |
| $121.50 | -5.81 | -4.6% | $124.95 | $125.45 | $121.13 | 580,500 | |
| $127.31 | +5.93 | +4.9% | $124.63 | $127.36 | $121.83 | 842,800 | |
| $121.38 | -0.03 | 0.0% | $119.75 | $122.14 | $118.09 | 640,800 | |
| $121.41 | +4.02 | +3.4% | $117.39 | $122.59 | $117.04 | 704,500 | |
| $117.39 | +2.97 | +2.6% | $112.90 | $118.04 | $110.05 | 468,600 | |
| $114.42 | +0.39 | +0.3% | $114.73 | $114.73 | $112.44 | 481,700 | |
| $114.03 | +4.41 | +4.0% | $110.22 | $115.00 | $109.09 | 961,000 | |
| $109.62 | +1.04 | +1.0% | $108.79 | $110.37 | $106.30 | 2,380,100 | |
| $108.58 | +1.06 | +1.0% | $106.63 | $109.05 | $106.04 | 404,900 | |
| $107.52 | +1.11 | +1.0% | $106.61 | $108.12 | $104.78 | 463,600 | |
| $106.41 | +0.93 | +0.9% | $105.00 | $107.04 | $103.37 | 510,900 | |
| $105.48 | +1.09 | +1.0% | $104.86 | $107.90 | $103.84 | 586,200 | |
| $104.39 | +4.08 | +4.1% | $101.75 | $104.95 | $100.53 | 601,500 | |
| $100.31 | -3.09 | -3.0% | $102.77 | $103.00 | $99.52 | 666,800 |
- Ticker
- NASDAQ:KYMR
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 29, 2026
Kymera Therapeutics Announces Third Quarter 2026 Financial Results and Reports Positive Results from the KT-579 Phase 1 Healthy Volunteer Trial
Latest earnings call · Oct 29, 2026
Kymera Therapeutics (NASDAQ:KYMR) Q3 2026 Earnings Call
Replay and transcript
Latest deck · September 2026
Investor Presentation (September 2026)
Investor deck · 72 slides
Calls
Replays
Kymera Therapeutics (NASDAQ:KYMR) Q3 2026 Earnings Call
Thu, Oct 29, 2026 · 8:30 AM ET
Watch TranscriptKymera Therapeutics (NASDAQ:KYMR) Q2 2026 Earnings Call
Wed, Aug 05, 2026 · 8:30 AM ET
Watch TranscriptKymera Therapeutics (NASDAQ:KYMR) Q1 2026 Earnings Call
Thu, Apr 30, 2026 · 8:30 AM ET
Watch Transcript
Latest news
Kymera Therapeutics Announces Third Quarter 2026 Financial Results and Reports Positive Results from the KT-579 Phase 1 Healthy Volunteer Trial
Oct 29, 2026
Closed $122.60 (+0.1%) on Oct 29, 2026
Kymera Therapeutics to Announce KT-579 Phase 1 Healthy Volunteer Trial Results on October 29, 2026
Oct 28, 2026
Closed $122.60 (+0.1%) on Oct 29, 2026
Kymera Therapeutics to Report Third Quarter 2026 Financial Results on October 29, 2026
Oct 22, 2026
Closed $110.76 (-0.1%) on Oct 23, 2026
Kymera Therapeutics Announces Presentations on KT-621, a First-in-Class, Oral STAT6 Degrader, at the European Respiratory Society and European Academy of Dermatology & Venereology Congresses
Sep 1, 2026
Closed $119.05 (+0.2%) on Sep 1, 2026
Kymera Therapeutics Announces Second Quarter 2026 Financial Results and Provides a Business Update
Aug 5, 2026
Closed $105.48 (+1.0%) on Aug 5, 2026
Kymera International Appoints Willson Ropp as Chief Executive Officer
Jul 29, 2026
Closed $105.25 (-0.9%) on Jul 29, 2026
Kymera Therapeutics to Report Second Quarter 2026 Financial Results on August 5, 2026
Jul 28, 2026
Closed $105.25 (-0.9%) on Jul 29, 2026
Kymera Therapeutics Appoints Terence Rooney, MD, as Chief Medical Officer
Jul 27, 2026
Closed $106.16 (-3.5%) on Jul 28, 2026
Kymera Therapeutics Appoints Elizabeth Laws, Ph.D., as Senior Vice President, Global Program Team Leader for KT-621, First-in-Class, Oral STAT6 Degrader
Jul 7, 2026
Closed $119.24 (+3.9%) on Jul 7, 2026
Kymera Therapeutics Appoints Felix J. Baker, Ph.D., as Chairman of the Board of Directors
Jun 24, 2026
Closed $99.87 (+1.6%) on Jun 24, 2026
Decks
Investor Presentation (September 2026)
Investor deck · 72 slides · September 2026
Q2 2026 Earnings Presentation
Earnings · 74 slides · Aug 5, 2026
JDA Annual Meeting 2026
Conference · 11 slides · Jun 12, 2026
ATS Annual Meeting, Respiratory Innovation Summit 2026
Conference · 9 slides · May 2026
Kymera Therapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 37 in the last 12 months · 202 in all · newest Oct 29, 2026 · oldest 2020
- Calls
- 19 calls with a replay · 19 with a transcript · latest Oct 29, 2026
- Decks
- 35 decks · latest September 2026
Where Kymera Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:KYMR · Home listing · This page | NASDAQ | United States | USD |
| BOATS:KYMR | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Kymera Therapeutics, Inc.